newsfilter
← Latest News
GlobeNewswire·

eFFECTOR Therapeutics to Present at JMP Securities Life Sciences Conference

SAN DIEGO and REDWOOD CITY, Calif., June 07, 2022 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ:EFTR), a biopharmaceutical company pioneering the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer, t